Saltar a casilla de búsquedaSaltar a navegaciónIr directamente al contenido principal

Papillary thyroid carcinoma in thyroglossal duct cyst: a Peruvian case series

  • José Luis Paz-Ibarrac, e(Autor)
    ,
  • Marialejandra Delgado Rojasg(Autor)
    ,
  • Edward Paucar Holgadoc(Autor)
    ,
  • Jenyfer María Fuentes-Mendozad(Autor)
    ,
  • Luis Concepción-Urteagab(Autor)
    ,
  • Juan Eduardo Quiroz-Aldavef(Autor)
  • ,
  • bUniversidad Nacional de Trujillo
    ,
  • cHospital Nacional Edgardo Rebagliati Martins, EsSalud
    ,
  • dUniversidad Científica del Sur
    ,
  • eUniversidad Nacional Mayor de San Marcos
    ,
  • fHospital de Apoyo Chepén
Producción científica: Contribución a una revista Artículo Revisión por expertos

Acceso abierto

Información de Publicación

Tipo de resultado

Producción científica: Contribución a una revista Artículo Revisión por expertos

Idioma original

Inglés

Número de artículo

EDM250139

Revista (Volumen, Número de Edición)

Endocrinology, Diabetes and Metabolism Case Reports (Volumen 2026, Número 1)

Hitos de publicación

  • Publicada - 01/2026

Estado de publicación

Publicada - 01/2026

ID de publicación externa

  • Scopus: 105028398242

Resumen

Papillary thyroid carcinoma (PTC) is the most frequent type of differentiated thyroid cancer, while thyroglossal duct cysts (TGDCs) are common congenital anomalies of the neck. The coexistence of PTC within a TGDC is exceptionally rare, with a reported incidence of less than 1.5%. We present three Peruvian cases of PTC arising in TGDCs. The patients (two females and one male; age range: 34–47 years) presented with progressive midline cervical masses of two to four years’ duration. All underwent cervical ultrasound, contrast-enhanced computed tomography, and fine-needle aspiration biopsy. Histopathology confirmed PTC, including classical and follicular variants. Surgical management varied: two patients underwent Sistrunk procedure alone, while one required Sistrunk surgery followed by total thyroidectomy, cervical lymph node dissection, and radioactive iodine (RAI) therapy. All patients remain disease-free after 6–12 years of follow-up. The diagnosis of carcinoma in TGDC is often incidental, but preoperative imaging and cytology can raise suspicion. Optimal management remains controversial; while the Sistrunk procedure may be sufficient in most cases of PTC confined to TGDC without extracapsular extension, in some scenarios, such as the presence of suspicious thyroid nodules, extracystic extension, and cervical lymph node metastasis, an additional thyroidectomy and RAI therapy may be warranted. In conclusion, PTC in TGDC is a rare entity with generally favorable prognosis. Early recognition, individualized treatment, and multidisciplinary decision-making are essential for optimal outcomes.

Objetivos de Desarrollo Sostenible

  • ODS 3: Salud y bienestar
    ODS 3: Salud y bienestar